The Worldwide Neurology Patient Monitoring Industry is Expected to Reach $7.4 Billion by 2030

    NEXT STORY
    Enzyvant Appoints Johanna Rossell as Chief Commercial Officer
    PREV STORY
    Evaxion Biotech Announces Publication of Clinical Data of EVX-01 Heading into Phase 2b in Collaboration with Merck
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    OSE Immunotherapeutics Reports First-Half 2018 Results and Provides a Corporate Update

    Key Highlights: Entered into a global immuno-oncology agreement in April 2018 with Boehringer Ingelheim ...

    author_avatar
    NASDAQ Market News

    Cesca Therapeutics Inc. Announces Commercial Launch of AXP® II System for Advanced Cord Blood Processing

    RANCHO CORDOVA, Calif., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) ...

    author_avatar
    NASDAQ Market News

    Five Prime Therapeutics to Host Conference Call on November 11th to Review Cabiralizumab Phase 1a/1b Data to be Presented in Late Breaking Oral Presentation at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting

    SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. ...

    author_avatar
    NASDAQ Market News